SEARCH

SEARCH BY CITATION

References

  • 1
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334:815820.
  • 2
    Weinstein JS, Poterucha JJ, Zein N, Wiesner RH, Persing DH, Rakela J. Epidemiology and natural history of hepatitis C infections in liver transplant recipients. J Hepatol 1995; 22(suppl 1):S154S159.
  • 3
    Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS, et al. Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients. Liver Transpl 2000; 6:553561.
  • 4
    Rosen H, Gretch DR, Oehlke M, Flora KD, Benner KG, Rabkin JM, Corless CL. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. Transplantation 1998; 65:11781182.
  • 5
    Sheiner PA. Hepatitis C after liver transplantation. Semin Liver Dis 2000; 20:201209.
  • 6
    Berenguer M, Lopez-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol 2001; 35:666678.
  • 7
    Sanchez-Fueyos A, Restrepo J-C, Quintó L, Bruguera M, Grande L, Sanchez Tapias JM, et al. Impact of the recurrence of hepatitis C infection after liver transplantation on the long term viability of the graft. Transplantation 2002; 73:5663.
  • 8
    Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl 2002; 8(suppl 1):S14S18.
  • 9
    Prieto M, Berenguer M, Rayon JM, Cordoba J, Arguello, Carrasco D, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes. Hepatology 1999; 29:250256.
  • 10
    Rosen H, Martin P. Hepatitis C infection in patients undergoing liver retransplantation. Transplantation 1998; 66:16121616.
  • 11
    Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28:823830.
  • 12
    Ghobrial RM, Farmer DG, Baquerizo A, Colquhoun S, Rosen H, Yersiz H, et al. Orthotopic liver transplantation for hepatitis C: Outcome, effect of immunosuppression and causes of retransplantation during an eight year single center experience. Ann Surg 1999; 6:824833.
  • 13
    Casavilla FA, Rakela J, Kapur S, Irish W, McMichael J, Demetris AJ, et al. Clinical outcome of patients hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. Liver Transpl Surg 1998; 4:448454.
  • 14
    Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122:889896.
  • 15
    Markmann JF, Markowitz JS, Yersiz H, Morrissey M, Farmer DG, Farmer DA, et al. Long-term survival after retransplantation of the liver. Ann Surg 1997; 226:408420.
  • 16
    Clemente G, Duran F, Loinaz C, Casanovas T, Rimola A, Jara R, et al. Late orthotopic liver retransplant: Indications and survival. Transplant Proc 1999; 31:511514.
  • 17
    Ghobrial RM. Retransplantation for recurrent hepatitis C. Liver Transpl 2002; 8(suppl 1):S38S43.
  • 18
    Sheiner PA, Schluger LK, Emre S, Thung SN, Lau JY, Guy SR, et al. Retransplantation for hepatitis C. Liver Transpl Surg 1997; 3:130136.
    Direct Link:
  • 19
    Feray C, Habsanne A, Samuel D, Farges O, Reynes M, Bismuth H. Poor prognosis of patients retransplanted for recurrent liver disease due to hepatitis C virus [abstract]. Hepatology 1995; 22:135A.
  • 20
    Casavilla FA, Lee R, Lim J, Kramer D, Irish W, Rakela J, Fung JJ. Outcome of liver retransplantation for recurrent hepatitis C infection [abstract]. Hepatology 1995; 22:153A.
  • 21
    Facciuto M, Heidt D, Guarrera J, Bodian CA, Miller CM, Emre S, et al. Retransplantation for late liver graft failure: Predictors of mortality. Liver Transpl 2000; 6:174179.
  • 22
    Doyle HR, Morelli F, McMichael J, Doria C, Aldrighetti L, Starzl TE, Marino IR. Hepatic retransplantation—An analysis of risk factors associated with outcome. Transplantation 1996; 61:14991505.
  • 23
    Feray C, Caccamo L, Alexander GJ, Ducot B, Gugenheim J, Casanovas T, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 1999; 117:619625.
  • 24
    Ghobrial RM, Gornbein J, Steadman R, Danino N, Markman JF, Ho HC, et al. Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg 2002; 236:315323.
  • 25
    Biggins SW, Beldecos A, Rabkin JM, Rosen HR. Retransplantation for hepatic allograft failure: Prognostic modeling and ethical considerations. Liver Transpl 2002; 8:313322.
  • 26
    Rosen HR, Madden JP, Martin P. A model to predict survival following liver retransplantation. Hepatology 1999; 29:365370.
  • 27
    Wong T, Devlin J, Rolando N, Heaton N, Williams R. Clinical characteristics affecting the outcome of liver transplantation. Transplantation 1997; 4:878882.
  • 28
    Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464470.
  • 29
    Ghobrial RM, Steadman R, Gornbein J, Lassman C, Holt CD, Chen P, et al. A ten year experience of liver transplantation for hepatitis C: Analysis of factors determining outcome in over 500 patients. Ann Surg 2001; 234:384394.
  • 30
    Rosen HR. Retransplantation for hepatitis C: Implications of different policies. Liver Transpl 2000; 6(suppl):S41S46.
  • 31
    Azoulay D, Linhares M, Huguet E, Delvart V, Castaing D, Adam R, et al. Decision for re-transplantation of the liver. Ann Surg 2002; 236:713721.
  • 32
    Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kumuth P, et al. Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124:9196.
  • 33
    Merion RM, Wolfe RA, Dykstra DM, Leichtman AB, Gilllespie B, Held P. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl 2003; 9:1218.
  • 34
    Brown RS, Kumar KS, Russo MW, Kinkhabwala N, Rudow DL, Harren P, et al. Model for End-Stage Liver Disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002; 8:278284.
  • 35
    Subramnian RM, McCashland TM, Bernard T, Lyden E, Schafer DF. Analysis of pretransplantation disease severity as a predictor of long-term posttransplantation survival [abstract]. Liver Transpl 2002; 8:C71.